206 related articles for article (PubMed ID: 36555216)
1. Gold Nanosystems Covered with Doxorubicin/DNA Complexes: A Therapeutic Target for Prostate and Liver Cancer.
Giráldez-Pérez RM; Grueso E; Montero-Hidalgo AJ; Luque RM; Carnerero JM; Kuliszewska E; Prado-Gotor R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555216
[TBL] [Abstract][Full Text] [Related]
2. Biocompatible DNA/5-Fluorouracil-Gemini Surfactant-Functionalized Gold Nanoparticles as Promising Vectors in Lung Cancer Therapy.
Giráldez-Pérez RM; Grueso E; Domínguez I; Pastor N; Kuliszewska E; Prado-Gotor R; Requena-Domenech F
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801142
[TBL] [Abstract][Full Text] [Related]
3. Use of Nanoparticles to Prevent Resistance to Antibiotics-Synthesis and Characterization of Gold Nanosystems Based on Tetracycline.
Giráldez-Pérez RM; Grueso EM; Jiménez-Aguayo R; Carbonero A; González-Bravo M; Kuliszewska E; Prado-Gotor R
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145689
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Antibacterial Effects of Amoxicillin and Gold Nanoparticles: A Therapeutic Option to Combat Antibiotic Resistance.
Giráldez-Pérez RM; Grueso EM; Carbonero A; Álvarez Márquez J; Gordillo M; Kuliszewska E; Prado-Gotor R
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627696
[TBL] [Abstract][Full Text] [Related]
5. Probing multifunctional azure B conjugated gold nanoparticles with serum protein binding properties for trimodal photothermal, photodynamic, and chemo therapy: Biophysical and photophysical investigations.
Sonia ; Singh A; Shivangi ; Kukreti R; Kukreti S; Kaushik M
Biomater Adv; 2022 Mar; 134():112678. PubMed ID: 35606220
[TBL] [Abstract][Full Text] [Related]
6. Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro.
Jędrzak A; Grześkowiak BF; Golba K; Coy E; Synoradzki K; Jurga S; Jesionowski T; Mrówczyński R
Int J Nanomedicine; 2020; 15():7923-7936. PubMed ID: 33116509
[TBL] [Abstract][Full Text] [Related]
7. Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.
Borker S; Pokharkar V
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):826-835. PubMed ID: 29749275
[TBL] [Abstract][Full Text] [Related]
8. Effects of doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines.
Tomoaia G; Horovitz O; Mocanu A; Nita A; Avram A; Racz CP; Soritau O; Cenariu M; Tomoaia-Cotisel M
Colloids Surf B Biointerfaces; 2015 Nov; 135():726-734. PubMed ID: 26340362
[TBL] [Abstract][Full Text] [Related]
9. Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxide.
Sodano F; Cavanagh RJ; Pearce AK; Lazzarato L; Rolando B; Fraix A; Abelha TF; Vasey CE; Alexander C; Taresco V; Sortino S
Biomater Sci; 2020 Mar; 8(5):1329-1344. PubMed ID: 31912808
[TBL] [Abstract][Full Text] [Related]
10. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.
Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100
[No Abstract] [Full Text] [Related]
11. [Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2].
Skaličková S; Löfelmann M; Gargulák M; Dočekalová M; Ruttkay-Nedecký B; Suchý P; Kepinská M; Kizek R
Klin Onkol; 2017; 30(Supplementum1):177-179. PubMed ID: 28471200
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic Transport.
Čížek M; Gargulák M; Sehnal K; Uhlířová D; Staňková M; Dočekalová M; Ruttkay-Nedecký B; Zídková J; Kizek R
Klin Onkol; 2019; 32(3):197-200. PubMed ID: 31216851
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content.
Rodríguez-Ruiz I; Delgado-López JM; Durán-Olivencia MA; Iafisco M; Tampieri A; Colangelo D; Prat M; Gómez-Morales J
Langmuir; 2013 Jul; 29(26):8213-21. PubMed ID: 23735159
[TBL] [Abstract][Full Text] [Related]
14. pH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles.
García Rubia G; Peigneux A; Jabalera Y; Puerma J; Oltolina F; Elert K; Colangelo D; Gómez Morales J; Prat M; Jimenez-Lopez C
Langmuir; 2018 Nov; 34(45):13713-13724. PubMed ID: 30394747
[TBL] [Abstract][Full Text] [Related]
15. Naked and Decorated Nanoparticles Containing H
Peira E; Chirio D; Sapino S; Chegaev K; Chindamo G; Salaroglio IC; Riganti C; Gallarate M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232858
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
17. Improved chemo-photothermal therapy of hepatocellular carcinoma using chitosan-coated gold nanoparticles.
Salem DS; Sliem MA; El-Sesy M; Shouman SA; Badr Y
J Photochem Photobiol B; 2018 May; 182():92-99. PubMed ID: 29653312
[TBL] [Abstract][Full Text] [Related]
18. Mechanochemically activated doxorubicin nanoparticles in combination with 40 MHz frequency irradiation on A-549 lung carcinoma cells.
Orel VE; Kudryavets YI; Satz S; Bezdenezhnih NA; Danko ML; Khranovskaya NN; Romanov AV; Dzyatkovskaya NN; Burlaka AP
Drug Deliv; 2005; 12(3):171-8. PubMed ID: 16025847
[TBL] [Abstract][Full Text] [Related]
19. [Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer].
Skaličková S; Gargulák M; Löffelmann M; Ruttkay-Nedecký B; Kepinská M; Parák T; Kizek R
Klin Onkol; 2017; 30(Supplementum1):174-176. PubMed ID: 28471199
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies.
Peira E; Chirio D; Battaglia L; Barge A; Chegaev K; Gigliotti CL; Ferrara B; Dianzani C; Gallarate M
J Microencapsul; 2016 Jun; 33(4):381-90. PubMed ID: 27358106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
